Veterinary Medicines

Endogard Plus Flavour Tablets for dogs

Authorised
  • Febantel
  • Praziquantel
  • Pyrantel embonate
Download as PDF

Product identification

Medicine name:
Endogard Plus Flavour Tablets for dogs
ENDOGARD COMPRIMIDOS CON SABOR PARA PERROS
Active substance:
  • Febantel
  • Praziquantel
  • Pyrantel embonate
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Febantel
    150.00
    milligram(s)
    /
    1.00
    Tablet
  • Praziquantel
    50.00
    milligram(s)
    /
    1.00
    Tablet
  • Pyrantel embonate
    144.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AC55
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Spain
Available in:
  • Spain
Package description:
  • Nature of container: Print and perforated Alu-Alu blister: 2 tablets (1 blister with 2 tablets), in a box.
  • Nature of container: Print and perforated Alu-Alu blister: 4 tablets (2 blisters with 2 tablets), in a box.
  • Nature of container: Print and perforated Alu-Alu blister: 10 tablets (1 blister with 10 tablets), in a box.
  • Nature of container: Print and perforated Alu-Alu blister: 30 tablets (3 blisters with 10 tablets), in a box.
  • Nature of container: Print and perforated Alu-Alu blister: 50 tablets (5 blisters with 10 tablets), in a box.
  • Nature of container: Print and perforated Alu-Alu blister: 100 tablets (10 blisters with 10 tablets), in a box.
  • Nature of container: Print and perforated Alu-Alu blister: 300 tablets (30 blisters with 10 tablets), in a box.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
  • Krka-Farma d.o.o.
  • Virbac
  • KRKA tovarna zdravil d.d. Novo mesto
Responsible authority:
  • Spanish Agency Of Medicines And Medical Devices
Authorisation number:
  • 2330 ESP
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0539/001
Concerned member states:
  • Austria
  • Belgium
  • Czechia
  • Denmark
  • Estonia
  • Germany
  • Greece
  • Hungary
  • Italy
  • Latvia
  • Lithuania
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 13/10/2024
Download
Spanish (PDF)
Published on: 13/12/2024
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 13/12/2024
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 20/11/2024
Download